To evaluate NR2-induced ferroptosis in vivo, GPX4 levels were quantified in nude mouse subcutaneous tumor models and KRASG12D/P53−/−-driven primary lung cancer mouse models, showing reduced expression after NR2 treatment (Fig. 7G and H). This evidence concerns the gene GPX4 and lung carcinoma.